Myriad Genetics Inc (MYGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 149,600 | 102,400 | 132,100 | 56,900 | 257,400 |
| Marketable Securities | N/A | N/A | 8,800 | 58,000 | 81,400 |
| Receivables | 115,300 | 121,200 | 114,300 | 101,600 | 91,300 |
| Inventories | 30,600 | 27,500 | 22,000 | 20,100 | 15,300 |
| TOTAL | $332,600 | $298,000 | $313,600 | $274,600 | $484,800 |
| Non-Current Assets | |||||
| PPE Net | 114,000 | 117,400 | 119,000 | 83,400 | 43,500 |
| Investments And Advances | 0 | 0 | 0 | 54,800 | 59,000 |
| Intangibles | 205,000 | 548,700 | 636,900 | 666,500 | 643,300 |
| Other Non-Current Assets | 55,000 | 63,500 | 77,000 | 119,400 | 90,100 |
| TOTAL | $374,000 | $729,600 | $832,900 | $924,100 | $835,900 |
| Total Assets | $706,600 | $1,027,600 | $1,146,500 | $1,198,700 | $1,320,700 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 30,000 | 32,300 | 25,800 | 28,800 | 29,600 |
| Accrued Expenses | 96,900 | 119,000 | 113,900 | 94,300 | 161,700 |
| TOTAL | $133,800 | $164,100 | $155,900 | $137,200 | $204,300 |
| Non-Current Liabilities | |||||
| Long Term Debt | 119,900 | 39,600 | 38,500 | N/A | N/A |
| Other Non-Current Liabilities | 84,900 | 122,800 | 168,900 | 175,700 | 112,800 |
| TOTAL | $204,800 | $162,400 | $207,400 | $175,700 | $148,600 |
| Total Liabilities | $338,600 | $326,500 | $363,300 | $312,900 | $352,900 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 93,508 | 91,309 | 89,875 | 81,224 | 80,023 |
| Common Shares | 900 | 900 | 900 | 800 | 800 |
| Retained earnings | -1,122,700 | -756,800 | -629,500 | -366,200 | -254,200 |
| Other shareholders' equity | 800 | -800 | -3,700 | -8,900 | -5,100 |
| TOTAL | $368,000 | $701,100 | $783,200 | $885,800 | $967,800 |
| Total Liabilities And Equity | $706,600 | $1,027,600 | $1,146,500 | $1,198,700 | $1,320,700 |